How significant is the impact of the four-drug combination on liver and kidney function?

Generally speaking, whether the quadruple therapy significantly affects liver and kidney function depends on specific circumstances. If used short-term, it usually has minimal impact on liver and kidney function; however, prolonged or inappropriate use may lead to more significant effects. If any discomfort occurs, prompt medical attention is recommended. Detailed analysis is as follows:

Quadruple therapy typically refers to a combination medication regimen used for treating Helicobacter pylori infection, generally including two antibiotics, a proton pump inhibitor, and a bismuth compound. If the quadruple therapy is used under a doctor's guidance for a short duration—usually no more than two weeks—and the patient has no pre-existing liver or kidney disease, its impact on liver and kidney function is generally minor.

Inappropriate long-term use of quadruple therapy, or self-extending the treatment course without medical supervision, may result in significant adverse effects on liver and kidney function, increasing the risk of liver and kidney damage.

During the course of treatment, patients should follow medical instructions carefully, taking the prescribed dosage at the scheduled times, and remain attentive to their body's responses. If any discomfort or suspected side effects occur, patients should contact their doctor immediately and should not alter the dosage or discontinue the medication on their own.